NDC 69616-265 - AGAMREE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
69616-265
Package NDCs from labels
69616-265-38
Manufacturer
Catalyst Pharmaceuticals, Inc. | Allpack Group AG | Farmabios S.p.A | Purna Pharmaceuticals NV/SA
Effective date
2026-01-22
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
AGAMREECatalyst Pharmaceuticals, Inc. | Allpack Group AG | Farmabios S.p.A | Purna Pharmaceuticals NV/SA2026-01-22HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69616-265-38AGAMREE100 mL in 1 BOTTLE, GLASSSUSPENSION100 mL40 mg in 1mL10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69616-265AGAMREE (VAMOROLONE) KIT [CATALYST PHARMACEUTICALS, INC.]7Unmatched20250413_fb376f09-cf9c-42b5-b4dd-02d5bcd73211.zip